SKYRIZI is a biologic that has been prescribed to more than 260,000 patients in the USA. * * Includes adults with: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s disease, and Ulcerative Colitis. Data is sourced from Symphony Health, an ICON plc Company, IDV ® and SKYRIZI Bridge Program data from April 2019 through November 2024.
SKYRIZI (Sky-RIZZ-ee; skaɪ rɪz zi), an injection, is known as an interleukin-23 (IL-23) inhibitor. † It works inside your body to treat adults with moderate to severe Ps who can take injections, pills (systemic therapy), or ultraviolet light therapy (phototherapy), and for adults with active PsA. * A biologic is a type of medication that is derived from living organisms, such as cells ...
Discover SKYRIZI, an FDA-approved biologic treatment for psoriasis. See full Safety and Prescribing Information.
The SKYRIZI design SKYRIZI works with your immune system, attaching to a specific protein that can cause inflammation. By attaching to this protein, SKYRIZI helps reduce chronic inflammation inside your body that leads to painful, discolored, itchy, burning plaques on the skin.
See SKYRIZI® results for the treatment of psoriasis. SKYRIZI® is an FDA-approved biologic treatment for psoriasis See full Safety and Prescribing Information.
Learn about SKYRIZI® for adults with moderate to severe Crohn’s disease. See full Safety and Prescribing Information.
The most common side effects of SKYRIZI in people treated for Crohn's disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach (abdominal) pain, injection site reactions, low red blood cells (anemia), fever, back pain, urinary tract infection, and rash.
Learn about how you could save on SKYRIZI® costs for your Psoriasis or Psoriatic Arthritis treatment. See full Safety & Prescribing Info.